A growing body of research suggests that the primary molecular mechanism underlying their anti-tumor effects is their inhibition of cancer cell growth and metastasis through targeting RTKs (EGFR, PDGFR, and VEGF/VEGFR). The gene discussed is VEGFA; the disease is neoplasm.